By mapping groups of protein networks, scientists better understand cancer and potential treatments.
Read moreScientists from QCRG and A*STAR reported new findings about COVID-19 neutralizing antibodies, which have important implications for their use as COVID-19 therapies.
Read moreQBI is launching a series of stories about research projects and experiences of scientists to provide a window into what our collaborative research looks like, and how beneficial and groundbreaking it can be.
Read moreWe want to take the opportunity to thank you for your continued support and engagement. Join us in reflecting on the accomplishments we’ve achieved together in 5 years.
Read moreFor International Day of Women and Girls in Science, QBI is drawing attention to the the important roles women play in science, as well as the continuous need for more diversity in STEM. We asked four QBI women to share their experiences and insights.
Read moreQBI COO, Jacqueline Fabius recently shared the story of QBI’s ongoing COVID-19 research saga story with family and friends. Her insider's account follows.
Read moreJanuary 6, 2020: Dr. Brian Shoichet leads a group of scientists in an effort to discover novel molecules with new mechanisms to treat pain.
Read more
December 4-5, 2019: QBI and Tel Aviv University presented an inaugural joint-symposium focused on computational biology and drug discovery.
Read moreOctober 16, 2019: Dr. Serena Sanulli recently led a study showing that HP1 reshapes the nucleosome core to promote heterochromatin phase separation.
Read moreSeptember 20, 2019: A 5-year MOU reinforces the links between scientists in San Francisco and Ireland.
Read more
September 5-6, 2019: Scientists from San Francisco and Paris came together to empower cancer research and dive into the possibility of forming promising partnerships.
Read more
May 27-29, 2019: QBI joined forces with FUB in May to launch their first joint symposium in Germany.
Read more
.png)
